Azka Ali, MD (@azkaalimd) 's Twitter Profile
Azka Ali, MD

@azkaalimd

Breast Medical Oncologist @clevelandclinic Taussig Can Inst. | Interested in experimental therapeutics #bcsm | @hemeoncgators and @MUSC_COM alum. Views = me

ID: 1297256820

linkhttps://my.clevelandclinic.org/staff/30132-azka-ali calendar_today25-03-2013 01:40:28

176 Tweet

323 Followers

189 Following

Stephanie Graff, MD, FACP, FASCO (@drsgraff) 's Twitter Profile Photo

A real-world analysis of patients MBC + mutESR1 tx with elacestrant. Time to discontinue (TTD) and next treatment (TTNT) were similiar to PFS in EMERALD despite recieving elacestrant beyond 2L #SABCS24 Rinath Jeselsohn OncoAlert

A real-world analysis of patients MBC + mutESR1 tx with elacestrant. Time to discontinue (TTD) and next treatment (TTNT) were similiar to PFS in EMERALD despite recieving elacestrant beyond 2L
#SABCS24 <a href="/RMJesel/">Rinath Jeselsohn</a> <a href="/OncoAlert/">OncoAlert</a>
Megan Kruse (@megankrusemd) 's Twitter Profile Photo

Proud of Azka Ali, MD for representing Cleveland Clinic and SWOG Cancer Research Network during today’s rapid fire oral session at #SABCS2024 with update of S0221 trial. Very interesting outcome differences by race noted and more analyses to come in the upcoming manuscript

Proud of <a href="/AzkaAliMD/">Azka Ali, MD</a> for representing <a href="/ClevelandClinic/">Cleveland Clinic</a> and <a href="/SWOG/">SWOG Cancer Research Network</a> during today’s rapid fire oral session at #SABCS2024 with update of S0221 trial. Very interesting outcome
differences by race noted and more analyses to come in the upcoming manuscript
OncLive.com (@onclive) 's Twitter Profile Photo

Thanks so much to Azka Ali, MD, of Cleveland Clinic, for sitting down with us at #SABCS24 to speak about alternative chemo dosing schedules in breast cancer! Check out our site for insights from Dr Ali and more! SABCS #bcsm #oncology onclive.com/conference/sab…

Thanks so much to <a href="/AzkaAliMD/">Azka Ali, MD</a>, of <a href="/clevelandclinic/">Cleveland Clinic</a>, for sitting down with us at #SABCS24 to speak about alternative chemo dosing schedules in breast cancer! Check out our site for insights from Dr Ali and more! <a href="/SABCSSanAntonio/">SABCS</a> #bcsm #oncology
onclive.com/conference/sab…
Katie Ryba (@katieryba) 's Twitter Profile Photo

Tune in to the latest Cleveland Clinic MD Cancer Advances podcast! Azka Ali, MD shares insights from #SABCS24 on ESR1 mutations, PI3K pathways, and advancing treatments for HR+/HER2- #breastcancer #CleClinicCancer cle.clinic/4gkO8DN

Oncology News Central (@oncnewscentral) 's Twitter Profile Photo

KEYNOTE-522: Exploratory #Biomarker analysis highlights TMB & T-cell-inflamed GEP as linked to better outcomes in early-stage #TripleNegativeBreastCancer. #Pembrolizumab shows efficacy across biomarker-defined subgroups. bit.ly/41Vka55 Azka Ali, MD #SABCS24 #TNBC

Oncology News Central (@oncnewscentral) 's Twitter Profile Photo

Slideshow: ADCs like #DatoDXd and next-gen endocrine therapies offer new options—but with more choice comes tougher clinical questions. bit.ly/3Z5qBjM #BreastCancer #Oncology #ADCs #EndocrineTherapy Komal Jhaveri Erin Cobain Azka Ali, MD Aditya Bardia, MD Julie Gralow

Stephanie Valente (@drstephvalente) 's Twitter Profile Photo

9th Annual Cleveland Breast Cancer Summit: Collaborating for a Cure- Friday August 8, 2025. Triple Negative Breast Cancer clevelandclinicmeded.com/live/courses/c…

9th Annual Cleveland Breast Cancer Summit: Collaborating for a Cure- Friday August 8, 2025. Triple Negative Breast Cancer

clevelandclinicmeded.com/live/courses/c…
Mark Lewis, MD, FASCO (@marklewismd) 's Twitter Profile Photo

It's been exactly 20 years since my first day of internship As I reflect on my disproportionate aging since then (gray hairs >>> wisdom), here are my 10 unsolicited recommendations for any colleague embarking on residency THE "ATTENDING ADVICE YOU DIDN'T ASK FOR" THREAD ...